NICE recommends Santhera’s Duchenne muscular dystrophy drug Agamree
The National Institute for Health and Care Excellence (NICE) has recommended Santhera Pharmaceuticals’ Agamree (vamorolone) to treat Duchenne muscular dystrophy (DMD). The drug has been recommended for use on the NHS in England, Wales and Northern Ireland …